Kfar Ha'Roe, Israel

Daniel Ofen


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Daniel Ofen

Introduction

Daniel Ofen is an accomplished inventor based in Kfar Ha'Roe, Israel. He has made significant contributions to the field of neurodegenerative disorders through his innovative research and patented inventions. His work focuses on developing novel compounds that target the brain and combat oxidative stress.

Latest Patents

Daniel Ofen holds a patent for "Brain targeted low molecular weight hydrophobic antioxidant compounds." This invention addresses the treatment of central nervous system neurodegenerative disorders such as Parkinson's, Alzheimer's, and Creutzfeldt-Jakob's diseases. Additionally, it offers potential solutions for conditions affecting peripheral tissues, including acute respiratory distress syndrome, amyotrophic lateral sclerosis, atherosclerotic cardiovascular disease, and multiple organ dysfunction, where oxidants are overproduced. He has 1 patent to his name.

Career Highlights

Throughout his career, Daniel Ofen has worked with notable companies, including Yissum and Mor. His expertise in the field has allowed him to contribute to groundbreaking research and development projects that aim to improve health outcomes for patients suffering from various disorders.

Collaborations

Daniel has collaborated with esteemed colleagues, including Daphne Atlas and Eldad Melamed. These partnerships have further enhanced his research and innovation efforts in the field of antioxidants and neurodegenerative diseases.

Conclusion

Daniel Ofen's work exemplifies the impact of innovative thinking in addressing critical health challenges. His contributions to the development of antioxidant compounds highlight the importance of research in improving treatment options for neurodegenerative disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…